Search

Your search keyword '"Aliprantis, Antonios O."' showing total 192 results

Search Constraints

Start Over You searched for: Author "Aliprantis, Antonios O." Remove constraint Author: "Aliprantis, Antonios O."
192 results on '"Aliprantis, Antonios O."'

Search Results

2. Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function

9. A phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of respiratory syncytial virus neutralizing monoclonal antibody MK ‐1654 in healthy Japanese adults

12. Control of bone resorption in mice by Schnurri-3

14. List of Contributors

18. Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis

19. 1013. Predicting RSV Efficacy for MK-1654 in Temperate and Tropical Climates using MBMA and Clinical Trial Simulation to Account for Seasonal Differences in RSV Force-of-Infection

20. 998. Forward and Reverse Translational Approaches to Predict Efficacy of the Neutralizing Respiratory Syncytial Virus (RSV) Antibody MK-1654

21. Contributors

24. Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection

25. HC[O.sub.3.sup.-]/[Cl.sup.-] anion exchanger SLC4A2 is required for proper osteoclast differentiation and function

26. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism

27. NFATc1 Balances Quiescence and Proliferation of Skin Stem Cells

30. Contributors

32. A Phase 1 Randomized, Double‐Blind, Placebo‐Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK‐1654 in Healthy Adults

33. A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults

36. A Phase 1 Randomized, Double‐Blind, Placebo‐Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK‐1654 in Healthy Adults.

37. A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults.

41. Author Correction: Towards an arthritis flare-responsive drug delivery system

42. Towards an arthritis flare-responsive drug delivery system

43. Interspecies Comparative Genomics Identifies Optimal Mouse Models of Systemic Sclerosis

47. Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics

Catalog

Books, media, physical & digital resources